Evaluation of masitinib in the treatment of Progressive Supranuclear Palsy

Update Il y a 4 ans
Reference: EUCTR2013-003740-23

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Assess efficacy of masitinib in the treatment of PSP definied by the evolution of Progressive Supranuclear Palsy Rating Scale (PSPRS) score from week 12 to week 48. Puntuación de la escala de evaluación de parálisis supranuclear progresiva (PSPRS) desde la semana 12 hasta la semana 48.


Inclusion criteria

  • Progressive supranuclear palsy ,Parálisis Supracraneal Progresiva

Links